Cerebral Small Vessels Disease Completed Phase Trials for Lidocaine (DB00281)

Also known as: Cerebral Small-vessel Disease / Cerebral Small Vessel Disease / Cerebral Small Vessel Diseases / Cerebral microangiopathy / Small vessel cerebrovascular disease (disorder) / Cerebral small vessel ischaemic disease / Cerebral small vessel ischemic disease

IndicationStatusPhase
DBCOND0072196 (Cerebral Small Vessels Disease)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs